Interagency Breast Cancer and Environmental Research Coordinating Committee

Not later than 6 months after October 8, 2008, the Secretary shall establish a committee, to be known as the Interagency Breast Cancer and Environmental Research Coordinating Committee (in this section referred to as the “Committee”). The Committee shall— develop a comprehensive strategy and advise the National Institutes of Health and other Federal agencies in the solicitation of proposals for collaborative, multidisciplinary research, including proposals to evaluate environmental and genomic factors that may be related to the etiology of breast cancer that would— not later than 2 years after the date of the establishment of the Committee, make recommendations to the Secretary— For the purposes of the Committee, when focusing on research to evaluate environmental and genomic factors that may be related to the etiology of breast cancer, nothing in this section shall be construed to restrict the Secretary from including other forms of cancer, as appropriate, when doing so may advance research in breast cancer or advance research in other forms of cancer. The Committee shall be composed of the following voting members: Not more than 7 voting Federal representatives as follows: The Committee shall include additional voting members appointed by the Secretary as follows: 6 members shall be appointed from among scientists, physicians, and other health professionals, who— The Committee shall include such nonvoting members as the Secretary determines to be appropriate. The voting members of the Committee shall select a chairperson from among such members. The selection of a chairperson shall be subject to the approval of the Director of NIH. The Committee shall meet at the call of the chairperson of the Committee or upon the request of the Director of NIH, but in no case less often than once each year. The Secretary shall review the necessity of the Committee in calendar year 2011 and, thereafter, at least once every 2 years.